GEN-003

· Genocea Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for GEN-003, covering 2017-10-16 to 2019-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection [Phase 2]